S&P 500Health Care· USA

DXCM

Status-Quo-Player

Dexcom

$63.12

-1.40%

Open $63.99·Prev $64.02

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

Dexcom's moat is its clinical accuracy leadership and deep integration into the automated insulin delivery ecosystem, which together create a switching cost that extends across the patient's entire diabetes management stack.

Published1 Apr 2026

UniverseS&P 500

SectorHealth Care

↓

Direction of Movement

Structural Strength Offset by Competitive and Margin Headwinds

ROC 200

-25.0%

Financials